62064-122-02 : NDC 2026 Code

62064-122-02 : Ibalizumab ( Trogarzo )

Additionally :

You can get information about “62064-122-02” NDC code in 62064-122-02 in HTML format

HTML | 62064-122-02 in TXT (Plain Text) format

TXT | 62064-122-02 in PDF (Portable Document Format)

PDF | 62064-122-02 in XML format

XML formats.

NDC Code : 62064-122-02 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "62064-122-02",
    "PackageDescription": "2 VIAL, SINGLE-USE in 1 CARTON (62064-122-02)  / 1.33 mL in 1 VIAL, SINGLE-USE (62064-122-01) ",
    "NDC11Code": "62064-0122-02",
    "ProductNDC": "62064-122",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Trogarzo",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Ibalizumab",
    "DosageFormName": "INJECTION, SOLUTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20180420",
    "EndMarketingDate": null,
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA761065",
    "LabelerName": "Theratechnologies Inc.",
    "SubstanceName": "IBALIZUMAB",
    "StrengthNumber": "150",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Antibodies, Monoclonal, Humanized [CS], CD4-directed Antibody Interactions [MoA], CD4-directed Blocking Antibody [EPC], HIV 1 Post-attachment Fusion Inhibitors [MoA], Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor [EPC]",
    "DEASchedule": null,
    "Status": "Deprecated",
    "LastUpdate": "2026-01-01",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20251231",
    "StartMarketingDatePackage": "20180420",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}